Tien Dam, M.D., Ph.D.

Vice President, Clinical Development

Professional Overview
Tien Dam, M.D., Ph.D. is an accomplished pharmaceutical executive with over 20 years of experience in clinical development and medical leadership roles focused on neurodegenerative disorders. As the Vice President of Clinical Development at Neumora, he oversees the strategic planning and execution of late-stage clinical trials for the company's pipeline of novel therapeutics targeting Alzheimer's disease, Parkinson's disease, and other movement disorders.

Experience Summary

Current Role
As Vice President of Clinical Development at Neumora, Dr. Dam is responsible for leading the company's global clinical development efforts. He oversees the design and implementation of late-stage clinical trials, ensures alignment with regulatory guidelines, and collaborates closely with the medical, regulatory, and commercial teams to advance Neumora's pipeline of transformative treatments for neurological conditions.

Career Progression
Prior to joining Neumora, Dr. Dam held various leadership positions at Biogen, where he most recently served as the Executive Medical Director and Head of the Neurodegeneration Development Unit. In this role, he spearheaded the clinical development of multiple investigational therapies for Alzheimer's disease, Parkinson's disease, and other movement disorders. Earlier in his career, Dr. Dam was a Medical Director at Merck, where he contributed to the clinical development of several neuroscience programs.

Before transitioning to the biopharmaceutical industry, Dr. Dam held academic appointments at Columbia University Medical Center and the University of California, San Diego, where he practiced as a board-certified geriatric and movement disorders specialist, conducted clinical research, and mentored medical students and residents.

Academic Background
Dr. Dam received his medical degree from the University of California, San Diego School of Medicine and completed his residency in internal medicine and fellowship in geriatric medicine at the same institution. He also holds a Ph.D. in neuroscience from the University of California, San Diego, with a focus on the neurophysiology of movement disorders.

Areas of Expertise

• Clinical development strategy and execution for neurodegenerative disorders

• Expertise in Alzheimer's disease, Parkinson's disease, and other movement disorders

• Translational research and biomarker development

• Regulatory affairs and collaborations with global health authorities

• Multidisciplinary team leadership and collaboration

Professional Impact
During his tenure at Biogen, Dr. Dam played a pivotal role in the clinical development of several investigational therapies for Alzheimer's disease and Parkinson's disease, including the successful completion of late-stage trials and regulatory submissions. His contributions have been instrumental in advancing the understanding and treatment of these debilitating neurological conditions.

Conclusion
With his extensive experience in clinical development, medical leadership, and academic research, Dr. Tien Dam is well-positioned to drive Neumora's clinical strategy and contribute to the advancement of transformative treatments for neurodegenerative disorders. His deep expertise and demonstrated track record of success make him a valuable asset to the company and the broader pharmaceutical industry.